Literature DB >> 30311684

An Intravenous Fish Oil-Based Lipid Emulsion Successfully Treats Intractable Pruritus and Cholestasis in a Patient with Microvillous Inclusion Disease.

Lorenzo Anez-Bustillos1, Duy T Dao1, Alexis K Potemkin1, Antonio R Perez-Atayde2, Bram P Raphael3, Alexandra N Carey3, Daniel S Kamin3, Jay R Thiagarajah3, McGreggor Crowley3, Kathleen M Gura3,4, Mark Puder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30311684      PMCID： PMC6507398          DOI： 10.1002/hep.30311

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.

Authors:  Emmanuel Gonzales; Sarah A Taylor; Anne Davit-Spraul; Alice Thébaut; Nadège Thomassin; Catherine Guettier; Peter F Whitington; Emmanuel Jacquemin
Journal:  Hepatology       Date:  2016-10-05       Impact factor: 17.425

2.  Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites.

Authors:  C C Miller; W Tang; V A Ziboh; M P Fletcher
Journal:  J Invest Dermatol       Date:  1991-01       Impact factor: 8.551

3.  MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.

Authors:  Muriel Girard; Florence Lacaille; Virginie Verkarre; Raphael Mategot; Gerard Feldmann; Alain Grodet; Frédérique Sauvat; Sabine Irtan; Anne Davit-Spraul; Emmanuel Jacquemin; Frank Ruemmele; Dominique Rainteau; Olivier Goulet; Virginie Colomb; Christophe Chardot; Alexandra Henrion-Caude; Dominique Debray
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

4.  Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.

Authors:  Yi-Ling Qiu; Jing-Yu Gong; Jia-Yan Feng; Ren-Xue Wang; Jun Han; Teng Liu; Yi Lu; Li-Ting Li; Mei-Hong Zhang; Jonathan A Sheps; Neng-Li Wang; Yan-Yan Yan; Jia-Qi Li; Lian Chen; Christoph H Borchers; Bence Sipos; A S Knisely; Victor Ling; Qing-He Xing; Jian-She Wang
Journal:  Hepatology       Date:  2017-03-23       Impact factor: 17.425
  4 in total
  3 in total

Review 1.  Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis.

Authors:  Sven C D van IJzendoorn; Qinghong Li; Yi-Ling Qiu; Jian-She Wang; Arend W Overeem
Journal:  Hepatology       Date:  2020-10       Impact factor: 17.425

2.  Inhalation of nebulized omega-3 fatty acids mitigate LPS-induced acute lung inflammation in rats: Implications for treatment of COPD and COVID-19.

Authors:  Chandrashekhar Kocherlakota; Banda Nagaraju; Narala Arjun; Akula Srinath; Kumar S D Kothapalli; J Thomas Brenna
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2022-03-30       Impact factor: 3.015

3.  A Molecular Mechanism Underlying Genotype-Specific Intrahepatic Cholestasis Resulting From MYO5B Mutations.

Authors:  Arend W Overeem; Qinghong Li; Yi-Ling Qiu; Fernando Cartón-García; Changsen Leng; Karin Klappe; Just Dronkers; Nai-Hua Hsiao; Jian-She Wang; Diego Arango; Sven C D van Ijzendoorn
Journal:  Hepatology       Date:  2020-04-23       Impact factor: 17.425
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.